Survival of classic Kaposi's sarcoma and risk of second cancer

British Journal of Cancer

Volumn 74, Issue 11, 1996, Pages 1812-1814

  Franceschi, S ^a   Arniani, S ^a,b   Balzi, D ^c   Geddes, M ^b  

^a CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

^b Sezione dell'IST   (Italy)

^c SA di Epidemiologia   (Italy)

Author keywords

Classic Kaposi's sarcoma; Second primary tumour; Survival

Indexed keywords

ADULT; AGED; ARTICLE; CANCER REGISTRY; CANCER SURVIVAL; FEMALE; HUMAN; KAPOSI SARCOMA; MAJOR CLINICAL STUDY; MALE; METASTASIS; PRIORITY JOURNAL; SURVIVAL RATE;

EID: 0029850462     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1996.635     Document Type: Article

References (15)

1. BIGGAR RJ, CURTIS RE, COTE TR, RABKIN CS AND MELBYE M. (1994). Risk of other cancers following Kaposi's sarcoma: relation to acquired immunodeficiency syndrome. Am. J. Epidemiol., 139, 362-368.
2. BRAMBILLA, L., LABIANCA R, BONESCHI V, FOSSATI S, DALLAVALLE G, FINZI AF AND LUPORINl G. (1994). Mediterranean Kaposi's sarcoma in the elderly. A randomized study of oral etoposide versus vinblastine. Cancer, 74, 2873-2878.
3. BRESLOW NE AND DAY NE. (1987). Statistical Methods in Cancer Research, Vol. II. The Design and Analysis of Cohort Studies. IARC Scientific Publication no. 82. IARC: Lyon.
4. DICTOR M AND ATTEWELL R. (1988). Epidemiology of Kaposi's sarcoma in Sweden prior to the acquired immunodeficiency syndrome. Int. J. Cancer, 42, 346-351.
5. FRANCESCHI S AND GEDDES M. (1995). Epidemiology of classic Kaposi's sarcoma, with special reference to Mediterranean population. Tumori, 81, 308-314.
6. GARCIA A, OLIVELLA F, VALDERRAMA S AND RODRIGUEZ G. (1989). Kaposi's sarcoma in Colombia. Cancer, 64, 2393-2398.
7. GEDDES M, FRANCESCHI S, BALZI D, ARNIANI S, GAFÀ L AND ZANETTI R ON BEHALF OF AIRT. (1995). Birthplace and classic Kaposi's sarcoma in Italy. J. Natl Cancer Inst., 87, 1015-1017.
8. HARRIS PJ. (1995). Treatment of Kaposi's sarcoma and other manifestations of AIDS with human chorionic gonadotropin. Lancet, 346, 118-119.
9. LUNARDI-ISKANDAR Y, BRYANT JL, ZEMAN RA, LAM VH, SAMANIEGO F, BESNIER JM, HERMANS P, THIERRY AR, GILL P AND GALLO RC. (1995). Tumorigenesis and metastasis of neoplastic Kaposi's sarcoma cell line in immunodeficient mice blocked by a human pregnancy hormone. Nature, 375, 64-68.
10. LUNDGREN JD, MELBYE M, PEDERSEN C, ROSENBERG PS AND GERSTOFT J FOR THE DANISH STUDY GROUP FOR HIV INFECTION. (1995). Changing patterns of Kaposi's sarcoma in Danish acquired immunodeficiency syndrome patients with complete follow-up. Am. J. Epidemiol., 141, 652-658.
11. PARKIN DM AND HAKULINEN T. (1991). Analysis of survival. In Cancer Registration: Principles and Methods, Parkin DM and Jenses OM. (eds) pp. 159-176. IARC Scientific Publication no. 95, IARC: Lyon.
12. SAFAI B, MIKÉ V, GIRALDO G, BETH E AND GOOD RA. (1980). Association of Kaposi's sarcoma with second primary malignancies: possible etiopathogenic implications. Cancer, 45, 1472-1479.
13. STEIN ME, SPENCER D, DANSEY R, PERNER Y, GUNTHER K AND BEZWODA WR. (1994). Lymphoproliferative disorders in non-AIDS-associated Kaposi's sarcoma. The Johannesburg Hospital experience, 1980-1992. S. Afr. Med. J., 84, 484-488.
14. TAPPERO JW, CONANT MA, WOLFE SE AND BERGER TG. (1993). Kaposi's sarcoma. Epidemiology, pathogenesis, histology, clinical spectrum, staging criteria and therapy. J. Am. Acad. Dermatol., 28, 371-395.
15. TEMPLETON AC AND BHANA D. (1975). Prognosis in Kaposi's sarcoma. J. Natl Cancer Inst., 55, 1301-1304.